Diagnosis of ovarian cancers using thoracoscopy: Three case reports and review of the literature

Nakao,Makoto; Oguri,Tetsuya; Miyazaki,Mikinori; Uemura,Takehiro; Takakuwa,Osamu; Kunii,Eiji; Ohkubo,Hirotsugu; Maeno,Ken; Sato,Shigeki

doi:10.3892/etm.2012.541

July 2012 Volume 4 Issue 1

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

July 2012 Volume 4 Issue 1

Full Size Image

Case Report

Diagnosis of ovarian cancers using thoracoscopy: Three case reports and review of the literature

Authors:
- Makoto Nakao
- Tetsuya Oguri
- Mikinori Miyazaki
- Takehiro Uemura
- Osamu Takakuwa
- Eiji Kunii
- Hirotsugu Ohkubo
- Ken Maeno
- Shigeki Sato
View Affiliations / Copyright

Affiliations: Department of Medical Oncology and Immunology, Nagoya City University, School of Medical Sciences, Nagoya 467-8601, Japan
Pages: 141-145
|
Published online on: April 11, 2012

https://doi.org/10.3892/etm.2012.541
Expand metrics +

Abstract

Thoracoscopy is a useful method for diagnosing plural lesions. We diagnosed 3 cases of ovarian adenocarcinoma by thoracoscopy. All patients were middle-aged and elderly women. Initial examination revealed intrathoracic lesions including pleural effusion, but intraperitoneal lesions were unclear. In all cases, adequate samples of tumor cells obtained using thoracoscopy were used in the identification of tumor origin. Elevated serum levels of cancer antigen 125 (CA-125) and Krebs von den lungen-6 (KL-6) were observed in 2 of the 3 patients. Diagnoses of ovarian cancer were based on immunohistochemical examinations and clinical course. This report describes the diagnostic usefulness of thoracoscopy and serum KL-6 in cases of ovarian cancer with predominantly intrathoracic lesions.

View Figures

View References

1	McLean AN, Bicknell SR, McAlpine LG and Peacock AJ: Investigation of pleural effusion: an evaluation of the new Olympus LTF semiflexible thoracofiberscope and comparison with Abram’s needle biopsy. Chest. 114:150–153. 1998.PubMed/NCBI
2	Kaburagi T, Kuroda H and Amemiya R: Thoracoscopy under local anesthesia focusing on findings of carcinomatous pleurisy. Kikanshigaku (J Jpn Society Bronchology). 26:326–330. 2004.
3	Canto A, Rivas J, Saumench J, Morera R and Moya J: Points to consider when choosing a biopsy method in cases of pleurisy of unknown origin. Chest. 84:176–179. 1983. View Article : Google Scholar : PubMed/NCBI
4	Pavlidis N, Briasoulis E, Hainsworth J and Greco FA: Diagnostic and therapeutic management of cancer of an unknown primary. Eur J Cancer. 39:1990–2005. 2003. View Article : Google Scholar : PubMed/NCBI
5	Casal RF, Eapen GA, Morice RC and Jimenez CA: Medical thoracoscopy. Curr Opin Pulm Med. 15:313–320. 2009. View Article : Google Scholar : PubMed/NCBI
6	Narushima M, Matsuishi J, Yamashita J and Suzuki H: Current situations of medical thoracoscopy for pleural deseases in Japan. Kikanshigaku (J Jpn Society Bronchology). 26:711–716. 2004.
7	Johnston WW: The malignant pleural effusion. A review of cytopathologic diagnoses of 584 specimens from 472 consecutive patients. Cancer. 56:905–909. 1985. View Article : Google Scholar : PubMed/NCBI
8	Kobayashi Y, Terauchi F, Nishi H, Fujitou A, Itou H and Isaka K: A case of advanced ovarian cancer upstaged on the bases of pleural washing cytology. J Obstet Gynaecol Res. 35:588–592. 2009. View Article : Google Scholar : PubMed/NCBI
9	Fukuoka T, Matsuoka E, Chiba S, Takayama S and Ohono S: Ovarian cancer that was initially diagnosed as malignant pleural effusion of unknown primary origin. J Rural Med. 4:41–44. 2009. View Article : Google Scholar
10	Chernow B and Sahn SA: Carcinomatous involvement of the pleura: an analysis of 96 patients. Am J Med. 63:695–702. 1977. View Article : Google Scholar : PubMed/NCBI
11	Cannistra SA: Cancer of the ovary. N Engl J Med. 351:2519–2529. 2004. View Article : Google Scholar : PubMed/NCBI
12	Nystrom JS, Weiner JM, Heffelfinger-Juttner J, Irwin LE, Bateman JR and Wolf RM: Metastatic and histologic presentations in unknown primary cancer. Semin Oncol. 4:53–58. 1977.PubMed/NCBI
13	Topalak O, Saygili U, Soyturk M, et al: Serum, pleural effusion, and ascites CA-125 levels in ovarian cancer and nonovarian benign and malignant diseases: a comparative study. Gynecol Oncol. 85:108–113. 2002. View Article : Google Scholar : PubMed/NCBI
14	Matsunaga T, Hiraiwa T, Kodaira H and Imai K: KL-6 is useful tumor marker for ovarian cancer. Nihon Fujinka Shyuyou Gakkai Zasshi (Jpn J Gynecol Oncol). 26:387–393. 2008.
15	Kohno N, Akiyama M, Kyoizumi S, Hakoda M, Kobuke K and Yamakido M: Detection of soluble tumor-associated antigens in sera and effusions using novel monoclonal antibodies, KL-3 and KL-6, against lung adenocarcinoma. Jpn J Clin Oncol. 18:203–216. 1988.PubMed/NCBI
16	Miyazaki K, Kurishima K, Kagohashi K, et al: Serum KL-6 levels in lung cancer patients with or without interstitial lung disease. J Clin Lab Anal. 24:295–299. 2010. View Article : Google Scholar : PubMed/NCBI
17	Ohnishi H, Yokoyama A, Kondo K, et al: Comparative study of KL-6, surfactant protein-A, surfactant protein-D, and monocyte chemoattractant protein-1 as serum markers for interstitial lung diseases. Am J Respir Crit Care Med. 165:378–381. 2002. View Article : Google Scholar : PubMed/NCBI

Journals

International Journal of Molecular Medicine

International Journal of Oncology

Molecular Medicine Reports

Oncology Reports

Experimental and Therapeutic Medicine

Oncology Letters

Biomedical Reports

Molecular and Clinical Oncology

World Academy of Sciences Journal

International Journal of Functional Nutrition

International Journal of Epigenetics

Medicine International

Diagnosis of ovarian cancers using thoracoscopy: Three case reports and review of the literature

This article is mentioned in:

Abstract

Figure 1

Figure 2

Figure 3

Related Articles